Clindamycin USP
Composition: Dalatic-300: Clindamycin USP 300mg Capsule.
Dalatic-300 Injection
(IV/IM): Clindamycin USP
300mg/2ml Injection.
Dalatic-600 Injection
(IV/IM): Clindamycin USP 600mg/4ml Injection.
Indications: Clindamycin is indicated in the treatment of
the following infections casued by susceptible anaerobic bacteria or
susceptible strains of gram positive bacteria such as streptococci, Pneumococci
and staphylococci in Lower respiratory tract infections, skin and soft tissue
infections, Bone and joint infections, Septicemia, Dental infections and also
indicated for the treatment of AIDS associated Pneumonia.
Dosage and
Adminstration: Dosage of Dalactic Capsule: Adult Patients: Serious infections: 150 to 300mg every 6
hours. More severe infections: 300 to 450mg every 6 hours. Pediatric Patients: Serious infections: 8 to 16mg/kg/day
divided into three or four equal doses. More severe infections: 16 to
20mg/kg/day divided into three or four equal doses. To avoid the possibility of
esophageal irritation, Clindamycin capsules should be taken with a full glass
of water. In cases of β-hemolytic streptococcalinfections, treatment should
continue for at least 10 days. Dosage of Dalatic Injection (IV/IM):
Adults: For Serious
infections: 600-1200mg/day in 2-4 equal doses. More severe infections,
1200-2700 mg/day in 2-4 equal doses. For more Serious infections, these doses
may have to be increased. Doses of as much as 4800 mg daily have been given
intravenously to adults.
For Detail Please see PDF File.
Use in pregnancy &
lactation: Pregnancy category B.
Packing: Dalatic-300: 2 x 7’s capsules in blister pack.
Dalatic-300 Injection
(IV/IM): 1 x 5’s ampoules in
blister pack.
Dalatic-600 Injection
(IV/IM): 1 x 3’s ampoules in
blister pack.
